Risk-factors for methadone-specific deaths in Scotland's methadone-prescription clients between 2009 and 2013

Gao, Lu and Dimitropoulou, Polyxeni and Robertson, J. Roy and McTaggart, Stuart and Bennie, Marion and Bird, Sheila M. (2016) Risk-factors for methadone-specific deaths in Scotland's methadone-prescription clients between 2009 and 2013. Drug and Alcohol Dependence, 167. pp. 214-223. ISSN 0376-8716

[img]
Preview
Text (Gao-etal-DAD2016-Risk-factors-for-methadone-specific-deaths-in-Scotland's-methadone-prescription)
Gao_etal_DAD2016_Risk_factors_for_methadone_specific_deaths_in_Scotland_s_methadone_prescription.pdf
Final Published Version
License: Creative Commons Attribution 4.0 logo

Download (482kB)| Preview

    Abstract

    Aim: To quantify gender, age-group and quantity of methadone prescribed as risk factors for drugs-related deaths (DRDs), and for methadone-specific DRDs, in Scotland's methadone-prescription clients. Design: Linkage to death-records for Scotland's methadone-clients with one or more Community Health Index (CHI)-identified methadone prescriptions during July 2009 to June 2013. Setting: Scotland's Prescribing Information System and National Records of Scotland. Measurements: Covariates defined at first CHI-identified methadone prescription, and person-years at-risk (pys) thereafter until the earlier of death-date or 31 December 2013. Methadone-specific DRDs were defined as: methadone implicated but neither heroin nor buprenorphine. Hazard ratios (HRs) were assessed using proportional hazards regression. Findings: Scotland's CHI-identified methadone-prescription cohort comprised 33,128 clients, 121,254 pys, 1,171 non-DRDs and 760 DRDs (6.3 per 1,000 pys), of which 362 were methadone-specific. Irrespective of gender, methadone-specific DRD-rate, per 1,000 pys, was higher in the 35+ age-group (4.2; 95% CI: 3.6-4.7) than for younger clients (1.9; 95% CI: 1.5-2.2). For methadone-specific DRDs, age-related HRs (e.g., 2.9 at 45+ years; 95% CI: 2.1-3.9) were steeper than for all DRDs (1.9; 95% CI: 1.5-2.4); there was no hazard-reduction for females; no gender by age-group interaction; and, unlike for all DRDs, the highest quintile for quantity of prescribed methadone at cohort-entry (>1960mg) was associated with increased HR (1.8; 95% CI: 1.3-2.5). Conclusion: Higher methadone-specific DRD rates in older clients, irrespective of gender, call for better understanding of methadone's pharmaco-dynamics in older, opioid-dependent clients, many with progressive physical or mental ill-health.